Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2025

Apr 29, 2025

284_dirs_2025-04-29_9e3b3f35-8b2f-425c-8f08-c91b44fa915e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-04-25

Reporting Person: Smart Dalton E. III (SVP Fin. - Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-04-25 Common Stock M 5000 $58.08 Acquired 12039.802 Direct
2025-04-25 Common Stock S 4262 $82.76 Disposed 7777.802 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-04-25 Stock Option (Right to Buy) $58.08 M 5000 Disposed 2025-04-30 Common Stock (5000) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.